Krensavage Asset Management
Latest statistics and disclosures from Krensavage Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are EXEL, UTHR, BIIB, TARO, CAH, and represent 69.12% of Krensavage Asset Management's stock portfolio.
- Added to shares of these 5 stocks: BNTX (+$11M), ENTA (+$6.7M), JAZZ, TARO, SNY.
- Started 1 new stock position in BNTX.
- Reduced shares in these 8 stocks: REGN (-$34M), ALKS (-$18M), UTHR (-$10M), EXEL (-$7.9M), BIIB (-$5.7M), CAH (-$5.1M), MASI, MURA.
- Sold out of its position in MASI.
- Krensavage Asset Management was a net seller of stock by $-63M.
- Krensavage Asset Management has $226M in assets under management (AUM), dropping by -19.98%.
- Central Index Key (CIK): 0001609251
Tip: Access up to 7 years of quarterly data
Positions held by Krensavage Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Krensavage Asset Management
Krensavage Asset Management holds 12 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Exelixis (EXEL) | 16.5 | $37M | -17% | 1.6M | 23.73 |
|
| United Therapeutics Corporation (UTHR) | 16.0 | $36M | -21% | 157k | 229.72 |
|
| Biogen Idec (BIIB) | 12.8 | $29M | -16% | 134k | 215.63 |
|
| Taro Pharmaceutical Industries (TARO) | 12.2 | $27M | 648k | 42.34 |
|
|
| Cardinal Health (CAH) | 11.7 | $26M | -16% | 236k | 111.90 |
|
| Enanta Pharmaceuticals (ENTA) | 8.7 | $20M | +51% | 1.1M | 17.46 |
|
| Jazz Pharmaceuticals (JAZZ) | 5.4 | $12M | 101k | 120.42 |
|
|
| Regeneron Pharmaceuticals (REGN) | 5.3 | $12M | -73% | 13k | 962.46 |
|
| Biontech Se (BNTX) | 4.9 | $11M | NEW | 120k | 92.25 |
|
| Sanofi-Aventis SA (SNY) | 3.3 | $7.3M | 151k | 48.60 |
|
|
| Alkermes (ALKS) | 3.1 | $7.0M | -71% | 258k | 27.07 |
|
| Mural Oncology (MURA) | 0.2 | $430k | -3% | 88k | 4.89 |
|
Past Filings by Krensavage Asset Management
SEC 13F filings are viewable for Krensavage Asset Management going back to 2014
- Krensavage Asset Management 2024 Q1 filed May 15, 2024
- Krensavage Asset Management 2023 Q4 filed Feb. 14, 2024
- Krensavage Asset Management 2023 Q3 filed Nov. 15, 2023
- Krensavage Asset Management 2023 Q2 filed Aug. 11, 2023
- Krensavage Asset Management 2023 Q1 filed May 16, 2023
- Krensavage Asset Management 2022 Q4 filed Feb. 15, 2023
- Krensavage Asset Management 2022 Q3 filed Nov. 15, 2022
- Krensavage Asset Management 2022 Q2 filed Aug. 16, 2022
- Krensavage Asset Management 2022 Q1 filed May 17, 2022
- Krensavage Asset Management 2021 Q4 filed Feb. 15, 2022
- Krensavage Asset Management 2021 Q3 filed Nov. 16, 2021
- Krensavage Asset Management 2021 Q2 filed Aug. 13, 2021
- Krensavage Asset Management 2021 Q1 filed May 18, 2021
- Krensavage Asset Management 2020 Q4 filed Feb. 17, 2021
- Krensavage Asset Management 2020 Q3 restated filed Dec. 8, 2020
- Krensavage Asset Management 2020 Q3 filed Nov. 17, 2020